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In crosses of mice of the high lymphoma strain, AKR, with mice of the low 
lymphoma strain,  RF,  the  lymphoma-resistant phenotype of the  parental  RF 
strain  is  transmitted by both  mendelian and nonmendelian mechanisms. The 
nonmendelian mechanism,  identified by  comparing  lymphoma  incidences  in 
reciprocal  F~  crosses  of the  two  strains,  involves a  maternal resistance factor 
(MRF) l transmitted by RF females to their progeny of both sexes (1). Evidence 
suggests that the main vehicle for transmission of the factor is the mother's milk 
(2). 
A crucial factor in lymphomagenesis in AKR mice is the life-long expression, 
beginning  soon  after  birth,  of high  levels  of endogenous  ecotropic  murine 
leukemia  virus  (E-MuLV)  in  infectious form  in  lymphoid tissues  (3).  Recent 
studies have demonstrated that mice of reciprocal  F~  crosses of AKR and RF 
differ even more markedly from each other in their levels of E-MuLV expression 
than in their lymphoma incidences; virus expression in (AKR ×  RF)F~ mice was 
only modestly decreased by comparison with parental strain AKR mice, whereas 
it  was  profoundly depressed  in  (RF  ×  AKR)F1  mice (4).  (By convention, the 
mother's strain is placed first in designating crosses.) Thus the RF strain may be 
categorized  as  MRF  +  and  the  AKR  strain  as  MRF-  with  reference  to  the 
transmission of maternal resistance both  to  lymphoma and to endogenous E- 
MuLV expression, leading to the obvious hypothesis that MRF-mediated sup- 
pression of virus expression is the basis of maternally transmitted resistance to 
lymphoma. 
In other genetic studies, we examined crosses of the RF and DBA/2 strains, 
both of which show only low incidences of spontaneous lymphoma and little or 
no E-MuLV expression (5).  F1 mice born of MRF  + RF mothers showed the low 
E-MuLV phenotype of the parental RF strain (i.e., virus-negative until 60-90 d 
of age, low-level expression thereafter in most mice), whereas F~  mice born of 
DBA/2 mothers expressed very high levels of infectious E-MuLV, comparable 
to those seen in AKR mice, already at weaning age. Thus, the DBA/2 strain is 
also MRF- by these criteria. 
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In  the  present  communication,  we  have  expanded  the  repertory  of mouse 
strains  for  these  experiments  to  include  SJL  (MRF ÷) and  ST/b  (MRF-).  We 
found that inoculation  of E-MuLV preparations into  1-4-d-old mice resulted in 
persistent expression of infectious virus in the MRF- strains,  DBA/2  and ST/b, 
but not  in the  MRF ÷ strains,  RF and  SJL.  In contrast,  inoculation  of the  virus 
into  30-d-old mice of MRF- strains did  not  lead to detectable virus expression 
but,  rather,  conferred  upon  females the  MRF ÷  phenotype.  Finally,  we  found 
that foster-nursing AKR newborns on RF mothers (MRF +) resulted not only in 
a markedly delayed appearance of lymphoma but also in greatly decreased levels 
of E-MuLV expression in the offspring. 
Materials and  Methods 
Animals.  Inbred mice of strains AKR/J,  RF/J,  SJL/J,  and  DBA/2J  were obtained 
from The Jackson Laboratory, Bar Harbor, ME. Experiments comparing mice from this 
source  with  mice of the  same strains  bred in  our colonies produced  indistinguishable 
results.  ST/bN  mice were bred in  our colony by brother/sister  mating starting from 
breeding pairs obtained through the courtesy of Dr. Carl Hansen, National Institutes of 
Health.  All  F1  mice were bred in  our colonies.  Only female mice were studied  in the 
experiments reported here. 
XC Plaque Assay.  Spleens and thymuses of individual  mice were homogenized sepa- 
rately in Ten Broeck tissue grinders in  2 ml of minimal essential medium (MEM) with 
20%  fetal calf serum (FCS) added.  Lymphoid cells were separated from supernates by 
centrifugation at  100 g  for 5  min at 4°C.  The cells in the pellet were counted  in the 
presence of trypan blue to assess viability (usually >90% viability) and then resuspended 
at 107/ml in fresh medium for use in virus assays. The supernate was used as the cell-free 
extract after two additional centrifugation steps at 4°C, one at 4,500 g for 15 min and a 
subsequent one at 7,000 g for 4 min. 
A clonal derivative of SC-1 mouse cells was used for detection of E-MuLV expression. 
Serial  dilutions  of both  lymphoid cells and  cell-free extracts  in  MEM  plus  20%  heat- 
inactivated FCS were used to infect monolayers of SC-1  cells that had been pretreated 
with Polybrene (16 #g/ml, Abbott Laboratories, North Chicago, IL) for 24 h. SC-1 cells 
were infected at a density of about 3.5 ×  105 cells/cm  2.  1 d later the infectious inoculum 
was removed and replaced by MEM containing 5% heat-inactivated FCS. 4 d after infection 
the SC-1 cells were exposed for 25-30 s to ultraviolet irradiation (60 erg/mm  2 per second) 
and then overlaid with XC rat cells.  2 d after adding XC cells the plates were fixed with 
methanol and stained with cresyl violet acetate.  Plaques containing syncytial cells were 
counted under a dissecting microscope. Results were expressed as plaque-forming units 
(PFU) per 107 viable spleen or thymus cells or PFU per 100 mg of tissue extract. 
Experimental Infection with E-MuLV.  Infectious E-MuLV-containing extracts were pre- 
pared from the spleens of 30- to 60-d-old AKR, (DBA/2  ×  RF)F1  [D2/RF] or (ST/b x 
RF)F1 [ST/RF] mice, all of which express high levels of virus activity from 3 wk of age. 
Only  freshly prepared  extracts  from  three  or  more donors  were  used.  Spleens  were 
homogenized in five times their weight of MEM plus 5% FCS. The homogenates were 
centrifuged for 8 min at 500 g; the supernates were removed and centrifuged for 15 min 
at  1,800 g and then for a  further 5 min at 6,000 g. Mice  1-5-<1 old received 0.1  ml of 
extract; a  1-in 30 gauge needle was used to make a long subcutaneous track, starting at 
the chest level, before depositing the inoculum ip. Mice of weanling age or older received 
a 0.1-ml inoculum directly intraperitoneally. 
b~duction of the MRF  + Phenotype.  Beginning  at  4-5  wk  of age,  DBA/2  and  ST/b 
females received three injections of 0.1  ml i.p.  of E-MuLV-containing extracts at  1-wk 
intervals.  1 wk later they were mated with AKR or RF males, and their progeny were 
tested for E-MuLV expression at 20-300 d of age. 508  MATERNAL  RESISTANCE  FACTOR 
Results 
E-MuLV Expression  in Mice  of Inbred Strains  and F1  Crosses.  The XC  plaque 
assay for infectious E-MuLV activity was the method used to examine both cell- 
free extracts  and  viable  cells,  plated  as  infectious centers,  from  spleens  and 
thymuses of individual 30-d-old females of selected inbred strains and FI crosses 
(Table  I).  AKR  mice  showed  the  expected  high  levels  of endogenous  virus 
activity in these lymphoid tissues (6), but, except for one DBA/2 mouse, animals 
of the other four strains tested were completely negative in these experiments. 
In other experiments not shown, older mice of the RF and SJL strains  have 
sometimes shown low to moderate levels of E-MuLV activity (5, 7), but DBA/2 
mice were rarely virus-positive, and ST/b mice have been consistently negative 
at all ages. 
Mice of FI crosses of AKR with either DBA/2 or ST/b expressed virus levels 
that were the same as or only slightly lower than those in parental strain AKR 
mice (Table I). Reciprocal crosses were indistinguishable in this respect, indicat- 
ing  that  DBA/2  and  ST/b  females are  phenotypically  MRF-.  By  contrast, 
pronounced differences existed between the E-MuLV levels of mice of reciprocal 
F~ crosses of AKR with both the RF and SJL strains.  In these latter intercross 
generations, mice born of AKR mothers showed AKR-like virus expression; mice 
born of SJL mothers, on the other hand, showed complete suppression of the 
virus in the thymus, and those born of RF mothers showed complete suppression 
in both the spleen and thymus. Thus females of the RF and SJL strains appeared 
to be, to different degrees, phenotypically MRF  +. 
Previous studies of intercrosses of the DBA/2 and RF strains have shown that 
20-d-old F~ mice born of MRF- DBA/2 mothers show high levels of E-MuLV 
activity (5) that are expressed from proviruses of the RF strain genome (8).  By 
contrast, F1 mice born of MRF  + RF mothers remain virus negative until late in 
life (5). Two parallels to these findings emerge from the results in Table I. First, 
reciprocal F~ crosses of RF and ST/b mice showed the same marked differences 
in E-MuLV expression seen in the crosses of RF with DBA/2, confirming that 
ST/b, like DBA/2, mothers were phenotypically MRF-. Second, crosses of SJL 
with either DBA/2 or ST/b mice also resembled those of RF with DBA/2 or 
ST/b in that E-MuLV was expressed in the progeny if the SJL parent was the 
father but not if it was the mother (cf. reference 9). In the DBA/2 by RF crosses 
studied earlier, the E-MuLV expressed was shown to originate from one or more 
proviruses of the RF parental strain (5).  By analogy, the virus activity detected 
in the present crosses of SJL with DBA/2 or ST/b was presumably expressed 
from  SJL  provirus(es).  Since  both  the  incidences and  the  titers  of E-MuLV 
detected in these SJL crosses were lower than those in the analogous RF crosses, 
it appears that the SJL provirus(es) are less readily expressed than those of the 
RF strain. 
E-MuLV Infection  of Neonates  and Juveniles.  Freshly prepared extracts of the 
spleens of AKR, D2/RF, or ST/RF young adults were used to infect recipient 
mice of various ages. Since extracts from the different sources produced indistin- 
guishable results in mice of any one strain, these results were pooled (Table II). 
Mice of the four strains that had proved to be E-MuLV negative at 30 d of age 
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TABLE  I 
E-MuL V Expression in Lymphoid Organs of  Mice of Various Inbred Strains and of Their 
Reciprocal Fl Crosses at 30 D of Age 
Percent E-MuLV-positive mice (Iogt0 virus titer) 
Mice  n  Spleen  Thymus 
Cells*  Extract*  Cells  Extract 
ST/b  10  0  0  0 
DBA/2  10  10 (2.2)  0  0 
SJL  10  0  0  0 
RF  10  0  0  0 
AKR  10  100 (5.5)  100 (4.6)  100 (3.0) 
(AKR x ST/b)F,  10  100 (5.3)  100 (4.5)  100 (4.0) 
(ST/b x AKR)F1  10  100 (5.2)  100 (4.8)  100 (3.6) 
(AKR x DBA/2)F1  10  100 (4.9)  100 (3.9)  100 (2.7) 
(DBA/2 x AKR)F~  10  100 (5.0)  100 (4.6)  100 (3.4) 
(AKR x SJL)F,  10  100 (5.6)  100 (4.8)  100 (5.0) 
(SJL x AKR)FI  12  50 (4.6)  42 (4.2)  0 
(AKR x  RF)F~  15  100 (4.7)  100 (3.5)  33 (2.5) 
(RF x AKR)F~  10  0  0  O 
(ST/b x RF)F,  10  100 (5.5)  100 (4.9)  100 (3.7) 
(RF x  ST/b)F~  10  0  0  O 
(DBA/2 x RF)F,  11  100 (4.6)  100 (3.2)  100 (2.2) 
(RF x  DBA/2)F~  10  0  0  0 
(ST/b x SJL)F~  10  80 (4.4)  50 (2.8)  40 (3.6) 
(SJL x ST/b)F,  10  0  0  0 
(DBA/2 x SJL)F,  20  80 (3.9)  35 (3.1)  O 
(SJL x DBA/2)F~  10  0  0  0 
o 
o 
o 
o 
100 (2.5) 
60 (2.8) 
60 (2.5) 
100 (2.6) 
20 (2.5) 
100 (2.6) 
0 
20 (2.2) 
0 
50 (3.0) 
o 
o 
o 
o 
o 
o 
o 
* Values for cells are the geometric mean numbers (logt0) of infectious centers induced in the XC 
assay per 10 ~ viable cells plated. 
* Values for tissue extracts are the geometric mean titers (log10)  in the XC assay of virus-induced 
plaques per 0.4 ml of extract. 
tissues  at  18-38  d  of age  showed  that  mice of the  MRF + strains,  RF and  SJL, 
remained virus negative except for 3 of 13 SJL mice that showed low virus titers 
in their spleen cells.  However,  mice of MRF-  strains DBA/2  and ST/b  became 
infected, showing high virus titers in the spleen and often moderate titers in the 
thymus;  this  infection  was long-lasting,  since neonatally  inoculated  MRF-  mice 
were tested at 2-8  mo of age showed a  similar pattern  of virus expression.  ST/ 
b  mice were slightly more  susceptible  to E-MuLV infection than DBA/2  mice. 
The  susceptibility  of MRF-  mice  to  E-MuLV  infection disappeared  with  age, 
however;  DBA/2  and  ST/b  mice  inoculated  at  "-'30  d  of age  remained  virus 
negative when tested  1 mo later (Table  II). 
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TABLE  II 
E-MuLV Expression in Mice of Various Strains after Virus Inoculation Neonatally 
or at 30 O of Age* 
Age of mice (d) at the 
time of: 
Mice  n 
Virus inocu- 
lation  Virus assay 
Percent E-MuLV-positive  mice (logl0 virus titer) 
Spleen  Thymus 
Cells*  Extract*  Cells  Extract 
SJL  1-2  22-30  13  23 (3.4)  0  0  0 
RF  1-4  18-30  25  0  0  0  0 
SY/b  1-4  24-34  24  100 (5.2)  96 (4.2)  88 (3.7)  42 (3.1) 
ST/b  1-4  108-252  24  100 (4.9)  86 (4.5)  82 (3.8)  50 (3.3) 
ST/b  30-32  55-60  15  0  0  0  0 
DBA/2  1-5  22-38  32  100 (4.7)  94 (3.2)  44 (3.2)  13 (3.8) 
DBA/2  1-5  72-248  37  100 (4.3)  59 (3.2)  24 (2.7)  0 
DBA/2  30-34  54-60  15  0  0  0  0 
* E-MuLV preparations inoculated consisted of freshly prepared cell-free extracts of spleens of young 
adult AKR, D2/RF, and ST/RF mice. 
* See footnotes to Table I. 
TABLE III 
Effect of Foster-nursing on E-MuLV Expression in Weanling AKR Mice 
Percent E-MuLV-positive  mice (log10 virus titer) 
Newborn  Foster  Age (d) at 
mice  mother  virus assay  n  Spleen  Thymus 
Cells  Extract  Cells  Extract 
AKR  --  20-32  10  100 (5.5)  100 (4.6)  100 (3.0)  100 (2.5) 
AKR  RF  23-34  18  38 (3.7)  22 (2.9)  0  0 
AKR  DBA/2  26-30  10  100 (5.8)  100 (5.0)  100 (3.5)  100 (2.0) 
foster mothers of either the RF or DBA/2  strains.  At 20-34 d  of age, E-MuLV 
activity detected in their spleens and thymuses was measured and compared with 
that  in  tissues of AKR progeny of the  same age  reared  by their  own  mothers 
(Table III). AKR mice fostered by MRF- DBA/2  mothers showed levels of virus 
activity indistinguishable  from those in  unfostered  controls.  Those fostered by 
MRF ÷ RF mothers,  on  the other  hand,  showed nearly total suppression  of the 
virus and,  in a  separate group, a  markedly lower and later lymphoma incidence 
(Fig.  1) by comparison with controls nursed by their own mothers. 
Induction  of the MRF ÷ Phenotype.  Female  DBA/2  and  ST/b  mice  that  had 
been  thrice  inoculated  with  E-MuLV as weanlings  were mated at  2  mo of age 
with  either  AKR  or  RF  males.  Levels of expression  of endogenous  E-MuLV 
were determined  in  the  F~  progeny of these  matings and  were compared with 
those in genetically identical populations of F~ mice born of uninoculated DBA/ 
2  and  ST/b  mothers.  The  results  (Table  IV) show  that  the  virus-inoculated 
females produced progeny that were significantly protected against endogenous 
virus expression by comparison with the control progeny of uninoculated females. MELAMEDOFF  ET  AL.  511 
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FIGURE  1.  Cumulative incidence of lymphoma in AKR mice nursed by their own mothers 
(0) and in AKR mice foster-nursed by RF mothers (O). 
TABLE  IV 
Induction of the MRF-positive Phenotype by Inoculation with E-MuL V-containing Spleen Extracts 
Mother in- 
Mice  oculated  Age (d) at  n 
with virus  virus assay 
from: 
Percent E-MuLV-positive mice 
(logl0 E-MuLV titer) 
Spleen  Thymus 
Cells  Extract  Cells  Extract 
(ST/b x  AKR)FI  --  28-55  12  100 (5.2)  100 (4.5)  100 (3.7)  50 (2.5) 
(ST/b x  AKR)F~  AKR  28-66  17  53 (4.3)  29 (2.7)  0  0 
(ST/b x  RF)F,  --  23-86  10  100 (5.5)  100 (4.9)  100 (3.7)  30 (3.0) 
(ST/b x  RF)F~  AKR  39-83  15  13 (2.0)  0  0  0 
(DBA/2xAKR)F~  --  31-36  ll  100(5.0)  100(4.6)  100(3.4)  18(2.5) 
(DBA/2 x  AKR)F~  AKR  25-48  17  88 (4.5)  29 (3.2)  12 (2.4)  0 
(DBA/2 x  RF)F]  --  23-80  20  100 (4.4!  100 (3.1)  80 (2.4)  10 (2.0) 
(DBA/2 x  RF)F~  AKR  31-80  16  13 (3.7)  0  0  0 
(DBA/2 x  RF)F~  ST/RF  20-35  27  27 (2.3)  0  0  0 
(DBA/2 x  RF)F,  D2/RF  21-30  17  29 (2.9)  0  0  0 
Reduced virus expression was apparent in both the spleen and the thymus in all 
four crosses studied. It appears that the inoculation of E-MuLV into these young 
adult females of MRF- strains, which did not lead to active virus infection,  did 
lead to induction of the MRF  + phenotype. 
Virus-containing  extracts  from  the  three  different  sources  used  (AKR,  ST/ 
RF,  and  D2/RF)  were  equally  effective  in  inducing  the  MRF  + phenotype  in 
DBA/2  females,  as  revealed  in  studies  of  E-MuLV  expression  among  their 
progeny  by  RF males  (Table  IV).  However,  the  MRF  + phenotype  induced  in 
DBA/2  and ST/b females by AKR extracts was less effective  in suppressing E- 
MuLV expression in their progeny by AKR than by RF males (Table IV). This 
latter finding is consistent with results from a small number of tests of E-MuLV 
expression  in  6-8-mo-old  mice  born of DBA/2  or ST/b  females  treated  with 
AKR extracts and then mated with AKR or RF males (data not shown); in these 
experiments,  these older progeny of AKR fathers showed a tendency to escape 512  MATERNAL  RESISTANCE  FACTOR 
from MRF-induced virus suppression,  whereas this escape was not seen in the 
older progeny of RF fathers. 
Discussion 
Both  the RF and SJL  mouse strains have been shown to be phenotypically 
MRF÷; F! progeny of either of these strains with the high E-MuLV AKR strain 
exhibited marked suppression of infectious E-MuLV expression by comparison 
with the AKR parent, but only if the mother, and not the father, was the RF or 
SJL parent. The transmission of this MRF within the inbred RF and SJL strains 
appears to be the main factor responsible for two related characteristics of these 
mice. First, mice of both strains, like AKR mice, possess one or more inducible 
E-MuLV proviruses in their genomes (10).  However, in contrast to AKR mice, 
these mice showed complete suppression of virus expression by the MRF until 
---3 mo of age in RF and even later in SJL mice, after which some individuals 
manifested escape from suppression  and expressed low to  moderate levels of 
infectious virus in their tissues. Second, in contrast with mice of MRF- strains, 
RF and SJL mice inoculated soon after birth with infectious E-MuLV-containing 
extracts remained virus-negative at 30 d of age. These findings provide support 
for the hypothesis that  the  MRF  is  the product of an  immune response and 
consists of antiviral antibodies able to suppress endogenous E-MuLV expression 
in infant mice long enough to permit maturation of a  native antiviral immune 
capacity in the developing babies. Such antibodies would be expected to cross- 
react strongly among the E-MuLV originating from proviruses of the AKR, RF, 
and SJL strains, and our data bear out this prediction. 
Preliminary studies  using a  radioimmunoassay for detection of anti-MuLV 
antibodies reactive with AKR  E-MuLV particles indicate that such antibodies 
were indeed present in high titers in the sera of RF mice but were also present 
at  equal  levels in  the  sera of MRF-  DBA/2  mice.  It  would follow from this 
observation that, if the MRF does consist of antiviral antibodies, these antibodies 
must represent a particular subset of the possible repertory ofantiviral antibodies. 
The basis  for the distinction between  MRF-associated and  MRF-independent 
antiviral antibodies remains to be clarified. 
The MRF- DBA/2 strain belongs to a different category of mice. It possesses 
a competent E-MuLV provirus (10) but expresses infectious virus only rarely and 
at very low levels. If, by analogy with MRF  ÷ strains, the low virus phenotype of 
DBA/2 mice is due to suppression by antiviral antibodies, these antibodies must 
be non-cross-reactive with E-MuLV originating from AKR, RF, and SJL provi- 
ruses, since (a) DBA/2 mothers provide no detectable anti-E-MuLV protection 
to their offspring by fathers of these strains, and (b) DBA/2 neonates are highly 
susceptible to chronic infection by exogenous E-MuLV. It seems more likely that 
the DBA/2  provirus  is  suppressed by some cis-acting  mechanism. The  ST/b 
strain resembles DBA/2 in all these characteristics, except that mice of this strain 
do not express detectable E-MuLV activity, consistent with their apparent lack 
of a complete E-MuLV provirus in their genome (10). 
Although DBA/2  and ST/b  mice were highly susceptible to infection with 
exogenous E-MuLV soon after birth, they had become resistant to the virus at 
30 d of age. This resistance apparently developed as a function of the acquisition MELAMEDOFF  ET  AL.  513 
of immunocompetence with respect to the virus; females hyperimmunized with 
virus-containing extracts became phenotypically MRF  + and, in crosses with RF 
males, produced up to seven litters of F1  progeny that remained markedly E- 
MuLV-suppressed to at least the age of 8 mo. This result bears comparison with 
recent findings of Schwarz  et  al.  (11),  who succeeded in  inducing the MRF  + 
phenotype in some AKR females by repeated inoculation, beginning immediately 
after birth, of a goat antiserum to the purified Friend MuLV envelope glycopro- 
tein, gp70, which cross-reacts with the homologous E-MuLV gene product. AKR 
mice are presumably MRF- because they produce infectious E-MuLV in large 
quantities soon after birth and thus become tolerant or paralyzed with respect 
to its antigens; either inoculation of heterologous anti-gp70 antibodies, as in the 
experiments of Schwarz  et  al.  (11),  or  maternal  transmission  of appropriate 
antiviral antibodies, as in AKR babies foster-nursed on RF mothers (Table IV), 
can interfere with E-MuLV expression until a  native immune response can be 
established.  This decreased virus expression coincides with a  significant delay 
and  decrease  in  lymphoma  incidence  in  both  sets  of experiments,  thereby 
providing  further  evidence  that  expression,  and  not  the  mere  presence,  of 
endogenous E-MuLV proviruses is crucial in spontaneous AKR lymphomagene- 
sis. 
Summary 
Females of the RF and SJL inbred mouse strains transmit to their progeny of 
both sexes a  nonmendelian maternal resistance factor (MRF) able to suppress 
the expression of endogenous ecotropic murine leukemia virus (E-MuLV). This 
MRF is demonstrable in crosses with AKR mice by comparing E-MuLV expres- 
sion in the spleens and thymuses of reciprocal F1 generations. DBA/2 and ST/ 
b  mice are MRF negative by these criteria.  Neonatal inoculation of E-MuLV- 
containing spleen extracts gives rise to persistent expression of infectious virus 
in  mice of the MRF-  but not the MRF  + strains.  However, inoculation of the 
virus  in  30-d-old  females of the  MRF-  strains  no  longer  leads  to  a  state  of 
persistent infection; instead, these females become MRF  + and transmit protection 
against E-MuLV expression to their progeny by AKR and RF males. The MRF 
appears to be transmitted to the progeny mainly through the milk, since foster- 
nursing AKR  neonates on  RF  (but  not  DBA/2)  mothers greatly reduces  E- 
MuLV  expression in  the progeny.  These RF-fostered AKR mice also show a 
reduced and delayed lymphoma incidence, a finding consistent with the idea that 
maternally transmitted  resistance  to  E-MuLV  expression  is  the  basis  for  the 
classic  maternal  resistance  to  lymphomagenesis seen  in  the  progeny  of  RF 
mothers. 
The technical assistance of Stanley Benjamin and Lillie Lopez is gratefully acknowledged. 
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